Clinical trials recruiting in Vejle, Denmark

Phase breakdown

Conditions recruiting in Vejle, Denmark

Recruiting trials in Vejle, Denmark

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
  NCT05354596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
  NCT07619131 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
  NCT05920356 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
  NCT06312176 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
  NCT07023289 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
  NCT07522073 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
  NCT07776509 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
  NCT06807424 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
  NCT07053423 · Phase: Phase 4 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  NCT06629779 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
  NCT07339423 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions
  NCT07343349 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
  NCT07206056 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male
• Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer
  NCT07296237 · Phase: Not specified · Ages: 18 Years and older · Sex: Female
• Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
  NCT07552584 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female)
• Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
  NCT05889247 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
  NCT06076811 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
  NCT03730922 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Dermatitis During Adjuvant Irradiation for BREAst Cancer:
  NCT06483477 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
  NCT06833749 · Phase: Phase 2 · Ages: 45 Years and older · Sex: All (male and female)
• Enhanced COPD Management in Suspected Lung Cancer Patients
  NCT07543601 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
  NCT06877949 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
  NCT06882993 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female)
• Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
  NCT07201194 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
  NCT07580716 · Phase: Phase 2 · Ages: 64 Years and older · Sex: All (male and female)
• Mediterranean Diet and Inequality in Early Breast Cancer
  NCT07007169 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
  NCT05572801 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients
  NCT05053997 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®
  NCT02354274 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
  NCT04680260 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Partial Breast Versus no Irradiation for Women With Early Breast Cancer
  NCT03646955 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female
• Perioperative Treatment With Tranexamic Acid in Melanoma
  NCT05899465 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
  NCT04613596 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Prehabilitation to Patients With Prostate Cancer
  NCT07162987 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
  NCT05404230 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer
  NCT04190589 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Reducing Breathlessness With Dronabinol in COPD Patients
  NCT06473701 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
  NCT06474806 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male
• Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
  NCT07460999 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
  NCT04095299 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
  NCT06136624 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
  NCT07222800 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
  NCT06685562 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
  NCT04291378 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Understanding and Tailored Treatment of Low Anterior Resection Syndrome
  NCT07573371 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Vejle, Denmark?

55 recruiting trials have at least one study site in Vejle, Denmark.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.